+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 85Years
All Genders
ID03042221

Study of Early Tumor Biopsy and Blood Tests to Find Survival Mechanisms After Targeted Treatment for Advanced Lung Cancer

Led by University of Colorado, Denver · Updated on 2026-02-20

100

Participants Needed

1

Research Sites

47 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying lung cancer patients with specific genetic mutations to understand how tumor cells survive early responses to targeted treatments called Tyrosine Kinase Inhibitors TKIs. This observational study focuses on non-small cell lung cancer NSCLC at advanced stages, aiming to identify early survival mechanisms in tumors to help develop better combination therapies and improve patient outcomes. Participants will be grouped based on their treatment type those receiving targeted therapy for gene mutations like EGFR, ALK, ROS1, or BRAF, and those receiving immunotherapy or chemotherapy plus immunotherapy without these mutations. The study includes collecting tumor biopsies and blood samples at the start and after about two weeks of treatment to analyze changes in gene and protein expression. Some patients may decline biopsy and participate through blood draws only. During the study, participants will undergo tumor biopsies if possible, blood draws, and ongoing monitoring of tumor response up to three years. Researchers will assess gene and protein changes early in treatment and evaluate the depth of tumor response over time. All participants must be able to consent and meet health criteria. The study support includes careful safety monitoring, with no prior systemic therapy allowed for metastatic disease.

CONDITIONS

Brief Title

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Research Team

B

Brandi Kubala

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here